Trifecta Capital Advisors, LLC

Position in PFE — Pfizer Inc

CIK 1962615 NORTHBROOK, IL

Position in PFE

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$102,990

+$90,540 QoQ

Shares Held

4,277

+755.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#2,537

of 2,821 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Trifecta Capital Advisors, LLC holds $49,578,365 across 11 Drug Manufacturers - General names. PFE ranks #8 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	25,670	$30,789,370
2	ABBV	AbbVie Inc.	41,305	$10,393,990
3	AMGN	Amgen Inc	16,502	$5,975,704
4	JNJ	Johnson & Johnson	3,836	$974,228
5	MRK	Merck & Co., Inc.	5,740	$737,590
6	GILD	Gilead Sciences, Inc.	3,202	$404,540
7	NVO	Novo Nordisk A S	4,016	$192,527
8	PFE	Pfizer Inc This page	4,277	$102,990

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$102,990	4,277	+755.4%	Shares	Sole	2026-08-03
2025-12-31	$12,450	500	-22.7%	Shares	Sole	2026-01-30
2025-09-30	$16,485	647	-82.5%	Shares	Sole	2025-11-03
2025-06-30	$89,615	3,697	+1.0%	Shares	Sole	2025-07-23
2025-03-31	$92,719	3,659	+35.4%	Shares	Sole	2025-04-21
2024-12-31	$71,710	2,703	-35.7%	Shares	Sole	2025-02-04
2024-09-30	$121,634	4,203	0.0%	Shares	Sole	2024-10-16
2024-06-30	$117,599	4,203	-37.3%	Shares	Sole	2024-08-07
2024-03-31	$186,119	6,707	-18.3%	Shares	Sole	2024-04-16
2023-12-31	$236,279	8,207	-10.8%	Shares	Sole	2024-01-25
2023-09-30	$305,064	9,197	+3.7%	Shares	Sole	2023-11-01
2023-06-30	$325,424	8,872	+4.7%	Shares	Sole	2023-08-14
2023-03-31	$345,657	8,472	+8.5%	Shares	Sole	2023-05-09
2022-12-31	$400,030	7,807	—	Shares	Sole	2023-01-18
No filing history on record for this holder in this stock.